Fountain Healthcare Partners Raises 131 Million USD.
The initial closing of its third fund, with €118 million of committed capital, exceeding its initial target raise of €100 million.
Fund III is a dedicated life science venture capital fund and brings Fountain’s total capital under management to €294 million. Fund III is expected to make 10 to 12 investments in predominantly private life science companies.
The €118 million capital raised was sourced from major domestic and international institutional investors including fund of funds, sovereign funds, corporate investors and family offices.
Fountain’s investment strategy focuses on building a balanced portfolio of companies with complementary risk and return profiles within the life science sector.
This strategy has resulted in a strong portfolio of investments for both Fund I and Fund II.